Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily

Overview

Journal Int J Bacteriol

Date 2015 Mar 10

PMID 25750934

Citations 51

Authors

Sanath Kumar

Mun Mun Mukherjee

Manuel F Varela

Affiliations

Soon will be listed here.

Abstract

Bacterial infections pose a serious public health concern, especially when an infectious disease has a multidrug resistant causative agent. Such multidrug resistant bacteria can compromise the clinical utility of major chemotherapeutic antimicrobial agents. Drug and multidrug resistant bacteria harbor several distinct molecular mechanisms for resistance. Bacterial antimicrobial agent efflux pumps represent a major mechanism of clinical resistance. The major facilitator superfamily (MFS) is one of the largest groups of solute transporters to date and includes a significant number of bacterial drug and multidrug efflux pumps. We review recent work on the modulation of multidrug efflux pumps, paying special attention to those transporters belonging primarily to the MFS.

Citing Articles

Exogenous plasmid capture to characterize tetracycline-resistance plasmids in sprouts obtained from retail in Germany.

Stein M, Brinks E, Habermann D, Cho G, Franz C Front Microbiol. 2025; 16:1538973.

PMID: 40012786 PMC: 11863281. DOI: 10.3389/fmicb.2025.1538973.

Antimicrobial resistance in fish and poultry: Public health implications for animal source food production in Nigeria, Egypt, and South Africa.

Okon E, Okocha R, Adesina B, Ehigie J, Alabi O, Bolanle A Front Antibiot. 2025; 1():1043302.

PMID: 39816413 PMC: 11732016. DOI: 10.3389/frabi.2022.1043302.

Genetic determinants of silver nanoparticle resistance and the impact of gamma irradiation on nanoparticle stability.

Mahfouz A, Eraqi W, El Hifnawi H, Shawky A, Samir R, Ramadan M BMC Microbiol. 2025; 25(1):18.

PMID: 39806286 PMC: 11727503. DOI: 10.1186/s12866-024-03682-x.

Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.

Bakhtiyari N, Farajnia S, Ghasemali S, Farajnia S, Pormohammad A, Saeidvafa S Infect Disord Drug Targets. 2024; 24(6):e260124226226.

PMID: 38284691 DOI: 10.2174/0118715265276529231214105423.

Antibiotic persistence and its impact on the environment.

Gangar T, Patra S 3 Biotech. 2023; 13(12):401.

PMID: 37982084 PMC: 10654327. DOI: 10.1007/s13205-023-03806-6.

References

Goswitz V, Brooker R . Structural features of the uniporter/symporter/antiporter superfamily. Protein Sci. 1995; 4(3):534-7. PMC: 2143070. DOI: 10.1002/pro.5560040319. View

NEYFAKH A . The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob Agents Chemother. 1992; 36(2):484-5. PMC: 188464. DOI: 10.1128/AAC.36.2.484. View

Bay D, Rommens K, Turner R . Small multidrug resistance proteins: a multidrug transporter family that continues to grow. Biochim Biophys Acta. 2007; 1778(9):1814-38. DOI: 10.1016/j.bbamem.2007.08.015. View

Lomovskaya O, Lewis K . Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci U S A. 1992; 89(19):8938-42. PMC: 50039. DOI: 10.1073/pnas.89.19.8938. View

Cattoir V, Poirel L, Nordmann P . Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob Agents Chemother. 2008; 52(10):3801-4. PMC: 2565908. DOI: 10.1128/AAC.00638-08. View

Mirza Z, Kumar A, Kalia N, Zargar A, Khan I . Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus. J Med Microbiol. 2011; 60(Pt 10):1472-1478. DOI: 10.1099/jmm.0.033167-0. View

George A . Multidrug resistance in enteric and other gram-negative bacteria. FEMS Microbiol Lett. 1996; 139(1):1-10. DOI: 10.1111/j.1574-6968.1996.tb08172.x. View

Kumar S, Lindquist I, Sundararajan A, Rajanna C, Floyd J, Smith K . Genome Sequence of Non-O1 Vibrio cholerae PS15. Genome Announc. 2013; 1(1). PMC: 3569316. DOI: 10.1128/genomeA.00227-12. View

Chung Y, Saier Jr M . SMR-type multidrug resistance pumps. Curr Opin Drug Discov Devel. 2001; 4(2):237-45. View

10.

Alekshun M, Levy S . Commensals upon us. Biochem Pharmacol. 2006; 71(7):893-900. DOI: 10.1016/j.bcp.2005.12.040. View

11.

Saier Jr M, Beatty J, Goffeau A, Harley K, Heijne W, Huang S . The major facilitator superfamily. J Mol Microbiol Biotechnol. 2000; 1(2):257-79. View

12.

Levy S . Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother. 1992; 36(4):695-703. PMC: 189356. DOI: 10.1128/AAC.36.4.695. View

13.

Alekshun M, Levy S . Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007; 128(6):1037-50. DOI: 10.1016/j.cell.2007.03.004. View

14.

He G, Zhang C, Crow R, Thorpe C, Chen H, Kumar S . SugE, a new member of the SMR family of transporters, contributes to antimicrobial resistance in Enterobacter cloacae. Antimicrob Agents Chemother. 2011; 55(8):3954-7. PMC: 3147620. DOI: 10.1128/AAC.00094-11. View

15.

Levy S . Active efflux, a common mechanism for biocide and antibiotic resistance. Symp Ser Soc Appl Microbiol. 2002; (31):65S-71S. View

16.

Someya Y, Yamaguchi A, Sawai T . A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter. Antimicrob Agents Chemother. 1995; 39(1):247-9. PMC: 162518. DOI: 10.1128/AAC.39.1.247. View

17.

Saidijam M, Benedetti G, Ren Q, Xu Z, Hoyle C, Palmer S . Microbial drug efflux proteins of the major facilitator superfamily. Curr Drug Targets. 2006; 7(7):793-811. DOI: 10.2174/138945006777709575. View

18.

Wright G . Molecular mechanisms of antibiotic resistance. Chem Commun (Camb). 2011; 47(14):4055-61. DOI: 10.1039/c0cc05111j. View

19.

Hassan K, Galea M, Wu J, Mitchell B, Skurray R, Brown M . Functional effects of intramembranous proline substitutions in the staphylococcal multidrug transporter QacA. FEMS Microbiol Lett. 2006; 263(1):76-85. DOI: 10.1111/j.1574-6968.2006.00411.x. View

20.

Flashner Y, Mamroud E, Tidhar A, Ber R, Aftalion M, Gur D . Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect Immun. 2004; 72(2):908-15. PMC: 321629. DOI: 10.1128/IAI.72.2.908-915.2004. View